Dermaliq Therapeutics, Inc.

Private

Wilmington, DelawareHealthcare & Life Scienceshttps://dermaliq.com

Last Round

Strategic

May 28, 2025

Total Funding Raised

$15M

Company Overview

Dermaliq Therapeutics, Inc. is a clinical-stage dermatology company developing topical therapies for follicular diseases and conditions using its proprietary hyliQ® technology platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B2C

Customer Profile

Revenue Share, Hardware Sales

AI Layer

Non-AI

Keywords

topical drug deliveryhyliQ platformdrug delivery platformdermatology therapeuticsalopecia treatmenthair loss treatmentpsoriasis treatmentEpidermolysis Bullosabutterfly skin diseasedrug formulationtargeted drug deliveryhair follicle deliveryclinical-stage pharmarare disease treatmentmedical aestheticslipophilic excipientsover-the-counter drugsOTC

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dermaliq Therapeutics, Inc. Comps

Public and private peers based on sector, stage, and business model.

Dermaliq Therapeutics, Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Dermaliq Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Strategic	May 28, 2025
Series B	Feb 5, 2025
Series A	Jan 18, 2022

View all Funding Rounds

Dermaliq Therapeutics, Inc. Investors

Notable investors and investment history

Dermaliq Therapeutics, Inc. investors
Investor	Rounds
DEBRA Research gGmbH	Strategic

View all Investors

Dermaliq Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Dermaliq Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Dermaliq Therapeutics, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersWilmington, Delaware

Employee Range6

Year Founded2021

Last FundingMay 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.